According to the 2025 study on minimizing muscle loss, strength training and adequate protein were identified as key factors in maintaining muscle while losing weight on GLP-1s
Bios: Tommy Sternberg, CFA, partner, global equity research analyst, covers large-cap healthcare companies
Medicare recipients with diabetes already have coverage for drugs like Ozempic and Mounjaro, so they wont be eligible for the new GLP-1 Bridge program
Glucagon-Like Peptide 1-Based Therapies for the Treatment of Type 2 Diabetes Mellitus. Edited by David M Nathan and Katya Rubinow, UpToDate, Wolters Kluwer, 9 Nov
The legal pathway for compounding exists under Section 503B of the Federal Food, Drug, and Cosmetic Act, which permits outsourcing facilities to produce medications in bulk without requiring patient-specific prescriptions